TRACEY NICHOLS: Open Payments
NPI 1962087734 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,717 in 130 payments from 17 companies in 2025. Trend: 2023 $2,135 · 2024 $2,822 · 2025 $2,717
Food & beverage: $2,662Education: $55
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 30 | $630 |
| Neurocrine BioSciences, Inc. | 15 | $472 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $248 |
| Alkermes, Inc. | 13 | $228 |
| E.R. Squibb & Sons, L.L.C. | 10 | $217 |
| Lundbeck LLC | 11 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $128 |
| HARMONY BIOSCIENCES LLC | 3 | $113 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| Corium, LLC | 4 | $90 |
Products named: REXULTI, INGREZZA, CAPLYTA, ARISTADA, COBENFY, TRINTELLIX, Jornay PM, Azstarys.
Industry payments across TX — which companies pay providers there.
